Skip to main content
Top
Published in: World Journal of Surgical Oncology 1/2014

Open Access 01-12-2014 | Research

The effect of chronic lymphocytic thyroiditis on patients with thyroid cancer

Authors: Yi Zhang, Xiao-peng Ma, Fu-sheng Deng, Zheng-rong Liu, Hou-qing Wei, Xi-hong Wang, Hao Chen

Published in: World Journal of Surgical Oncology | Issue 1/2014

Login to get access

Abstract

Background

The purpose of this study was to investigate the association between chronic lymphocytic thyroiditis (CLT) and malignant tumors of the thyroid.

Methods

A retrospective review of 647 patients who underwent thyroid surgery at the Department of Breast and Thyroid Surgery in Anhui Provincial Hospital, China in 2012 was performed. The clinicopathological characteristics of patients with thyroid malignancies and CLT were collected. CLT was diagnosed by histopathological method.

Results

Among 647 patients, 144 patients had thyroid malignancies and 108 patients had been diagnosed with CLT. Moreover, in total, 44 patients had thyroid malignancies coexistent with CLT: forty-one (93.2%) patients had been diagnosed with the papillary thyroid cancer (PTC); two (4.5%) patients suffered from medullary carcinoma; and one (2.3%) patient suffered from lymphoma. The morbidity of thyroid malignancies in patients with CLT was significantly higher than that in patients without CLT (40.7% versus 18.6%; P <0.001). A female preponderance was observed in the patients with CLT compared with those without CLT (P <0.001). There was no statistically significant difference in the tumor size (P = 0.073), multifocality (P = 0.0871), neck lymph node metastasis (P = 0.350), age (P = 0.316), microcarcinoma (P = 0.983) and tumor-node-metastasis (TNM) stage (P = 0.949) between the patients of thyroid malignancies with CLT and without CLT.

Conclusions

Female predominance was observed in patients with CLT. CLT may have no effect on the progression of thyroid malignant tumor. Nevertheless, the influences of CLT on the prognosis of the thyroid carcinoma still need to be investigated with a larger sample size.
Literature
2.
go back to reference Ahn D, Heo SJ, Park JH, Kim JH, Sohn JH, Park JY, Park SK, Park J: Clinical relationship between Hashimoto's thyroiditis and papillary thyroid cancer. Acta Oncol. 2011, 50: 1228-1234. 10.3109/0284186X.2011.602109.CrossRefPubMed Ahn D, Heo SJ, Park JH, Kim JH, Sohn JH, Park JY, Park SK, Park J: Clinical relationship between Hashimoto's thyroiditis and papillary thyroid cancer. Acta Oncol. 2011, 50: 1228-1234. 10.3109/0284186X.2011.602109.CrossRefPubMed
3.
go back to reference Davies L, Welch HG: Increasing incidence of thyroid cancer in the United States, 1973–2002. JAMA. 2006, 295: 2164-2167. 10.1001/jama.295.18.2164.CrossRefPubMed Davies L, Welch HG: Increasing incidence of thyroid cancer in the United States, 1973–2002. JAMA. 2006, 295: 2164-2167. 10.1001/jama.295.18.2164.CrossRefPubMed
4.
go back to reference Koo BS, Yoon YH, Kim JM, Choi EC, Lim YC: Predictive factors of level IIb lymph node metastasis in patients with papillary thyroid carcinoma. Ann Surg Oncol. 2009, 16: 1344-1347. 10.1245/s10434-009-0367-y.CrossRefPubMed Koo BS, Yoon YH, Kim JM, Choi EC, Lim YC: Predictive factors of level IIb lymph node metastasis in patients with papillary thyroid carcinoma. Ann Surg Oncol. 2009, 16: 1344-1347. 10.1245/s10434-009-0367-y.CrossRefPubMed
5.
go back to reference Mercante G, Frasoldati A, Pedroni C, Formisano D, Renna L, Piana S, Gardini G, Valcavi R, Barbieri V: Prognostic factors affecting neck lymph node recurrence and distant metastasis in papillary microcarcinoma of the thyroid: results of a study in 445 patients. Thyroid. 2009, 19: 707-716. 10.1089/thy.2008.0270.CrossRefPubMed Mercante G, Frasoldati A, Pedroni C, Formisano D, Renna L, Piana S, Gardini G, Valcavi R, Barbieri V: Prognostic factors affecting neck lymph node recurrence and distant metastasis in papillary microcarcinoma of the thyroid: results of a study in 445 patients. Thyroid. 2009, 19: 707-716. 10.1089/thy.2008.0270.CrossRefPubMed
6.
go back to reference Sciuto R, Romano L, Rea S, Marandino F, Sperduti I, Maini CL: Natural history and clinical outcome of differentiated thyroid carcinoma: a retrospective analysis of 1503 patients treated at a single institution. Ann Oncol. 2009, 20: 1728-1735. 10.1093/annonc/mdp050.CrossRefPubMed Sciuto R, Romano L, Rea S, Marandino F, Sperduti I, Maini CL: Natural history and clinical outcome of differentiated thyroid carcinoma: a retrospective analysis of 1503 patients treated at a single institution. Ann Oncol. 2009, 20: 1728-1735. 10.1093/annonc/mdp050.CrossRefPubMed
7.
go back to reference Udelsman R, Chen H: The current management of thyroid cancer. Adv Surg. 1999, 33: 1-27.PubMed Udelsman R, Chen H: The current management of thyroid cancer. Adv Surg. 1999, 33: 1-27.PubMed
8.
go back to reference Mack LA, Pasieka JL: An evidence-based approach to the treatment of thyroid lymphoma. World J Surg. 2007, 31: 978-986. 10.1007/s00268-005-0768-z.CrossRefPubMed Mack LA, Pasieka JL: An evidence-based approach to the treatment of thyroid lymphoma. World J Surg. 2007, 31: 978-986. 10.1007/s00268-005-0768-z.CrossRefPubMed
9.
go back to reference Hiromatsu Y, Satoh H, Amino N: Hashimoto's thyroiditis: history and future outlook. Hormones (Athens). 2013, 12: 12-18. Hiromatsu Y, Satoh H, Amino N: Hashimoto's thyroiditis: history and future outlook. Hormones (Athens). 2013, 12: 12-18.
10.
go back to reference Dailey ME, Lindsay S, Skahen R: Relation of thyroid neoplasms to Hashimoto disease of the thyroid gland. AMA Arch Surg. 1955, 70: 291-297. 10.1001/archsurg.1955.01270080137023.CrossRefPubMed Dailey ME, Lindsay S, Skahen R: Relation of thyroid neoplasms to Hashimoto disease of the thyroid gland. AMA Arch Surg. 1955, 70: 291-297. 10.1001/archsurg.1955.01270080137023.CrossRefPubMed
11.
go back to reference Dayan CM, Daniels GH: Chronic autoimmune thyroiditis. N Engl J Med. 1996, 335: 99-107. 10.1056/NEJM199607113350206.CrossRefPubMed Dayan CM, Daniels GH: Chronic autoimmune thyroiditis. N Engl J Med. 1996, 335: 99-107. 10.1056/NEJM199607113350206.CrossRefPubMed
12.
go back to reference Pearce EN, Farwell AP, Braverman LE: Thyroiditis. N Engl J Med. 2003, 348: 2646-2655. 10.1056/NEJMra021194.CrossRefPubMed Pearce EN, Farwell AP, Braverman LE: Thyroiditis. N Engl J Med. 2003, 348: 2646-2655. 10.1056/NEJMra021194.CrossRefPubMed
13.
go back to reference Holm L-E, Blomgren H, Löwhagen T: Cancer risks in patients with chronic lymphocytic thyroiditis. N Engl J Med. 1985, 312: 601-604. 10.1056/NEJM198503073121001.CrossRefPubMed Holm L-E, Blomgren H, Löwhagen T: Cancer risks in patients with chronic lymphocytic thyroiditis. N Engl J Med. 1985, 312: 601-604. 10.1056/NEJM198503073121001.CrossRefPubMed
14.
go back to reference Lee JH, Kim Y, Choi JW, Kim YS: The association between papillary thyroid carcinoma and histologically proven Hashimoto's thyroiditis: a meta-analysis. Eur J Endocrinol. 2013, 168: 343-349. 10.1530/EJE-12-0903.CrossRefPubMed Lee JH, Kim Y, Choi JW, Kim YS: The association between papillary thyroid carcinoma and histologically proven Hashimoto's thyroiditis: a meta-analysis. Eur J Endocrinol. 2013, 168: 343-349. 10.1530/EJE-12-0903.CrossRefPubMed
15.
go back to reference Cipolla C, Sandonato L, Graceffa G, Fricano S, Torcivia A, Vieni S, Latteri S, Latteri MA: Hashimoto thyroiditis coexistent with papillary thyroid carcinoma. Am Surg. 2005, 71: 874-878.PubMed Cipolla C, Sandonato L, Graceffa G, Fricano S, Torcivia A, Vieni S, Latteri S, Latteri MA: Hashimoto thyroiditis coexistent with papillary thyroid carcinoma. Am Surg. 2005, 71: 874-878.PubMed
16.
go back to reference Moshynska OV, Saxena A: Clonal relationship between Hashimoto thyroiditis and thyroid lymphoma. J Clin Pathol. 2008, 61: 438-444. 10.1136/jcp.2007.051243.CrossRefPubMed Moshynska OV, Saxena A: Clonal relationship between Hashimoto thyroiditis and thyroid lymphoma. J Clin Pathol. 2008, 61: 438-444. 10.1136/jcp.2007.051243.CrossRefPubMed
17.
go back to reference Okayasu I, Fujiwara M, Hara Y, Tanaka Y, Rose NR: Association of chronic lymphocytic thyroiditis and thyroid papillary carcinoma. A study of surgical cases among Japanese, and white and African Americans. Cancer. 1995, 76: 2312-2318. 10.1002/1097-0142(19951201)76:11<2312::AID-CNCR2820761120>3.0.CO;2-H.CrossRefPubMed Okayasu I, Fujiwara M, Hara Y, Tanaka Y, Rose NR: Association of chronic lymphocytic thyroiditis and thyroid papillary carcinoma. A study of surgical cases among Japanese, and white and African Americans. Cancer. 1995, 76: 2312-2318. 10.1002/1097-0142(19951201)76:11<2312::AID-CNCR2820761120>3.0.CO;2-H.CrossRefPubMed
18.
go back to reference Kim EY, Kim WG, Kim WB, Kim TY, Kim JM, Ryu JS, Hong SJ, Gong G, Shong YK: Coexistence of chronic lymphocytic thyroiditis is associated with lower recurrence rates in patients with papillary thyroid carcinoma. Clin Endocrinol. 2009, 71: 581-586. 10.1111/j.1365-2265.2009.03537.x.CrossRef Kim EY, Kim WG, Kim WB, Kim TY, Kim JM, Ryu JS, Hong SJ, Gong G, Shong YK: Coexistence of chronic lymphocytic thyroiditis is associated with lower recurrence rates in patients with papillary thyroid carcinoma. Clin Endocrinol. 2009, 71: 581-586. 10.1111/j.1365-2265.2009.03537.x.CrossRef
19.
go back to reference Kashima K, Yokoyama S, Noguchi S, Murakami N, Yamashita H, Watanabe S, Uchino S, Toda M, Sasaki A, Daa T: Chronic thyroiditis as a favorable prognostic factor in papillary thyroid carcinoma. Thyroid. 1998, 8: 197-202. 10.1089/thy.1998.8.197.CrossRefPubMed Kashima K, Yokoyama S, Noguchi S, Murakami N, Yamashita H, Watanabe S, Uchino S, Toda M, Sasaki A, Daa T: Chronic thyroiditis as a favorable prognostic factor in papillary thyroid carcinoma. Thyroid. 1998, 8: 197-202. 10.1089/thy.1998.8.197.CrossRefPubMed
20.
go back to reference Hunt JL, Baloch ZW, Swalsky PA, Trusky CL, Finkelstein S, LiVolsi VA: Loss of heterozygosity mutations to tumor suppressor genes in cytologically atypical areas in chronic lymphocytic thyroiditis. Endocr Pathol. 2002, 13: 321-329. 10.1385/EP:13:4:321.CrossRefPubMed Hunt JL, Baloch ZW, Swalsky PA, Trusky CL, Finkelstein S, LiVolsi VA: Loss of heterozygosity mutations to tumor suppressor genes in cytologically atypical areas in chronic lymphocytic thyroiditis. Endocr Pathol. 2002, 13: 321-329. 10.1385/EP:13:4:321.CrossRefPubMed
21.
go back to reference Diklić A, Zivaljević V, Paunović I, Kalezić N, Tatić S: Surgical procedures in patients with thyroid autoimmune disease. Srp Arh Celok Lek. 2005, 133: 77-83.CrossRefPubMed Diklić A, Zivaljević V, Paunović I, Kalezić N, Tatić S: Surgical procedures in patients with thyroid autoimmune disease. Srp Arh Celok Lek. 2005, 133: 77-83.CrossRefPubMed
22.
go back to reference Shih M-L, Lee JA, Hsieh C-B, Yu J-C, Liu H-D, Kebebew E, Clark OH, Duh Q-Y: Thyroidectomy for Hashimoto's thyroiditis: complications and associated cancers. Thyroid. 2008, 18: 729-734. 10.1089/thy.2007.0384.CrossRefPubMed Shih M-L, Lee JA, Hsieh C-B, Yu J-C, Liu H-D, Kebebew E, Clark OH, Duh Q-Y: Thyroidectomy for Hashimoto's thyroiditis: complications and associated cancers. Thyroid. 2008, 18: 729-734. 10.1089/thy.2007.0384.CrossRefPubMed
23.
go back to reference Kebebew E, Treseler PA, Ituarte PH, Clark OH: Coexisting chronic lymphocytic thyroiditis and papillary thyroid cancer revisited. World J Surg. 2001, 25: 632-637. 10.1007/s002680020165.CrossRefPubMed Kebebew E, Treseler PA, Ituarte PH, Clark OH: Coexisting chronic lymphocytic thyroiditis and papillary thyroid cancer revisited. World J Surg. 2001, 25: 632-637. 10.1007/s002680020165.CrossRefPubMed
24.
go back to reference Singh B, Shaha AR, Trivedi H, Carew JF, Poluri A, Shah JP: Coexistent Hashimoto's thyroiditis with papillary thyroid carcinoma: impact on presentation, management, and outcome. Surgery. 1999, 126: 1070-1077. 10.1067/msy.2099.101431.CrossRefPubMed Singh B, Shaha AR, Trivedi H, Carew JF, Poluri A, Shah JP: Coexistent Hashimoto's thyroiditis with papillary thyroid carcinoma: impact on presentation, management, and outcome. Surgery. 1999, 126: 1070-1077. 10.1067/msy.2099.101431.CrossRefPubMed
25.
go back to reference Repplinger D, Bargren A, Zhang Y-W, Adler JT, Haymart M, Chen H: Is Hashimoto's thyroiditis a risk factor for papillary thyroid cancer?. J Surg Res. 2008, 150: 49-52. 10.1016/j.jss.2007.09.020.PubMedCentralCrossRefPubMed Repplinger D, Bargren A, Zhang Y-W, Adler JT, Haymart M, Chen H: Is Hashimoto's thyroiditis a risk factor for papillary thyroid cancer?. J Surg Res. 2008, 150: 49-52. 10.1016/j.jss.2007.09.020.PubMedCentralCrossRefPubMed
26.
27.
go back to reference Haugen BR: Management of the patient with progressive radioiodine non-responsive disease. Semin Surg Oncol. 1999, 16: 34-41. 10.1002/(SICI)1098-2388(199901/02)16:1<34::AID-SSU7>3.0.CO;2-2.CrossRefPubMed Haugen BR: Management of the patient with progressive radioiodine non-responsive disease. Semin Surg Oncol. 1999, 16: 34-41. 10.1002/(SICI)1098-2388(199901/02)16:1<34::AID-SSU7>3.0.CO;2-2.CrossRefPubMed
28.
go back to reference Yoon Y-H, Kim HJ, Lee JW, Kim JM, Koo BS: The clinicopathologic differences in papillary thyroid carcinoma with or without co-existing chronic lymphocytic thyroiditis. Eur Arch Otorhinolaryngol. 2012, 269: 1013-1017. 10.1007/s00405-011-1732-6.CrossRefPubMed Yoon Y-H, Kim HJ, Lee JW, Kim JM, Koo BS: The clinicopathologic differences in papillary thyroid carcinoma with or without co-existing chronic lymphocytic thyroiditis. Eur Arch Otorhinolaryngol. 2012, 269: 1013-1017. 10.1007/s00405-011-1732-6.CrossRefPubMed
29.
go back to reference Jeong JS, Kim HK, Lee C-R, Park S, Park JH, Kang S-W, Jeong JJ, Nam K-H, Chung WY, Park CS: Coexistence of chronic lymphocytic thyroiditis with papillary thyroid carcinoma: clinical manifestation and prognostic outcome. J Korean Med Sci. 2012, 27: 883-889. 10.3346/jkms.2012.27.8.883.PubMedCentralCrossRefPubMed Jeong JS, Kim HK, Lee C-R, Park S, Park JH, Kang S-W, Jeong JJ, Nam K-H, Chung WY, Park CS: Coexistence of chronic lymphocytic thyroiditis with papillary thyroid carcinoma: clinical manifestation and prognostic outcome. J Korean Med Sci. 2012, 27: 883-889. 10.3346/jkms.2012.27.8.883.PubMedCentralCrossRefPubMed
30.
go back to reference Pages F, Galon J, Dieu-Nosjean M, Tartour E, Sautes-Fridman C, Fridman W: Immune infiltration in human tumors: a prognostic factor that should not be ignored. Oncogene. 2010, 29: 1093-1102. 10.1038/onc.2009.416.CrossRefPubMed Pages F, Galon J, Dieu-Nosjean M, Tartour E, Sautes-Fridman C, Fridman W: Immune infiltration in human tumors: a prognostic factor that should not be ignored. Oncogene. 2010, 29: 1093-1102. 10.1038/onc.2009.416.CrossRefPubMed
31.
go back to reference Mahmoud S, Lee A, Paish E, Macmillan R, Ellis I, Green A: The prognostic significance of B lymphocytes in invasive carcinoma of the breast. Breast Cancer Res Treat. 2012, 132: 545-553. 10.1007/s10549-011-1620-1.CrossRefPubMed Mahmoud S, Lee A, Paish E, Macmillan R, Ellis I, Green A: The prognostic significance of B lymphocytes in invasive carcinoma of the breast. Breast Cancer Res Treat. 2012, 132: 545-553. 10.1007/s10549-011-1620-1.CrossRefPubMed
33.
go back to reference Pacifico F, Leonardi A: Role of NF-κB in thyroid cancer. Mol Cell Endocrinol. 2010, 321: 29-35. 10.1016/j.mce.2009.10.010.CrossRefPubMed Pacifico F, Leonardi A: Role of NF-κB in thyroid cancer. Mol Cell Endocrinol. 2010, 321: 29-35. 10.1016/j.mce.2009.10.010.CrossRefPubMed
34.
go back to reference Kim ES, Lim DJ, Baek KH, Lee JM, Kim MK, Kwon HS, Song KH, Kang MI, Cha BY, Lee KW: Thyroglobulin antibody is associated with increased cancer risk in thyroid nodules. Thyroid. 2010, 20: 885-891. 10.1089/thy.2009.0384.CrossRefPubMed Kim ES, Lim DJ, Baek KH, Lee JM, Kim MK, Kwon HS, Song KH, Kang MI, Cha BY, Lee KW: Thyroglobulin antibody is associated with increased cancer risk in thyroid nodules. Thyroid. 2010, 20: 885-891. 10.1089/thy.2009.0384.CrossRefPubMed
35.
go back to reference Loh K-C, Greenspan FS, Dong F, Miller TR, Yeo PP: Influence of lymphocytic thyroiditis on the prognostic outcome of patients with papillary thyroid carcinoma. J Clin Endocrinol Metab. 1999, 84: 458-463. 10.1210/jcem.84.2.5443.CrossRefPubMed Loh K-C, Greenspan FS, Dong F, Miller TR, Yeo PP: Influence of lymphocytic thyroiditis on the prognostic outcome of patients with papillary thyroid carcinoma. J Clin Endocrinol Metab. 1999, 84: 458-463. 10.1210/jcem.84.2.5443.CrossRefPubMed
36.
go back to reference Meier DW, Woolner LB, Beahrs OH, Mc CW: Parenchymal findings in thyroidal carcinoma: pathologic study of 256 cases. J Clin Endocrinol Metab. 1959, 19: 162-171. 10.1210/jcem-19-1-162.CrossRefPubMed Meier DW, Woolner LB, Beahrs OH, Mc CW: Parenchymal findings in thyroidal carcinoma: pathologic study of 256 cases. J Clin Endocrinol Metab. 1959, 19: 162-171. 10.1210/jcem-19-1-162.CrossRefPubMed
37.
go back to reference Burek CL, Rose NR: Autoimmune thyroiditis and ROS. Autoimmun Rev. 2008, 7: 530-537. 10.1016/j.autrev.2008.04.006.CrossRefPubMed Burek CL, Rose NR: Autoimmune thyroiditis and ROS. Autoimmun Rev. 2008, 7: 530-537. 10.1016/j.autrev.2008.04.006.CrossRefPubMed
38.
go back to reference Flynn JC, McCormick DJ, Brusic V, Wan Q, Panos JC, Giraldo AA, David CS, Kong YCM: Pathogenic human thyroglobulin peptides in HLA-DR3 transgenic mouse model of autoimmune thyroiditis. Cell Immunol. 2004, 229: 79-85. 10.1016/j.cellimm.2004.07.002.CrossRefPubMed Flynn JC, McCormick DJ, Brusic V, Wan Q, Panos JC, Giraldo AA, David CS, Kong YCM: Pathogenic human thyroglobulin peptides in HLA-DR3 transgenic mouse model of autoimmune thyroiditis. Cell Immunol. 2004, 229: 79-85. 10.1016/j.cellimm.2004.07.002.CrossRefPubMed
39.
go back to reference Spencer CA: Clinical utility of thyroglobulin antibody (TgAb) measurements for patients with differentiated thyroid cancers (DTC). J Clin Endocrinol Metab. 2011, 96: 3615-3627. 10.1210/jc.2011-1740.CrossRefPubMed Spencer CA: Clinical utility of thyroglobulin antibody (TgAb) measurements for patients with differentiated thyroid cancers (DTC). J Clin Endocrinol Metab. 2011, 96: 3615-3627. 10.1210/jc.2011-1740.CrossRefPubMed
Metadata
Title
The effect of chronic lymphocytic thyroiditis on patients with thyroid cancer
Authors
Yi Zhang
Xiao-peng Ma
Fu-sheng Deng
Zheng-rong Liu
Hou-qing Wei
Xi-hong Wang
Hao Chen
Publication date
01-12-2014
Publisher
BioMed Central
Published in
World Journal of Surgical Oncology / Issue 1/2014
Electronic ISSN: 1477-7819
DOI
https://doi.org/10.1186/1477-7819-12-277

Other articles of this Issue 1/2014

World Journal of Surgical Oncology 1/2014 Go to the issue